Brazil Vacuum Blood Collection Tube Market

Brazil Vacuum Blood Collection Tube Market Insights Forecasts to 2035

• The Brazil Vacuum Blood Collection Tube Market Size Was Estimated at USD 103.95 Million in 2024
• The Market Size is Expected to Grow at a CAGR of Around 3.1% from 2025 to 2035
• The Brazil Vacuum Blood Collection Tube Market Size is Expected to Reach USD 145.50 Million by 2035

According to a research report published by Decision Advisior & Consulting, the Brazil Vacuum Blood Collection Tube Market size is anticipated to reach USD 145.50 million by 2035, growing at a CAGR of 3.1% from 2025 to 2035. The Brazil vacuum blood collection tube market is driven by rising demand for safe and efficient blood sampling, growth in diagnostic testing, expanding healthcare infrastructure, increasing prevalence of chronic diseases, and greater adoption of advanced laboratory technologies across hospitals, clinics, and diagnostic centers.

Market Overview

A vacuum blood collection tube is a sterile, sealed tube containing a pre-measured vacuum that draws a specific amount of blood directly from a patient’s vein during phlebotomy. These tubes may contain additives for testing and ensure safe, accurate, and contamination-free blood collection for laboratory diagnostics. Additionally, the Brazil vacuum blood collection tube market grows due to increasing diagnostic testing needs, rising chronic disease incidence, expansion of public and private healthcare facilities, improved laboratory automation, and higher awareness of safe blood handling. Growing adoption of preventive healthcare and the modernization of medical laboratories further accelerate market demand. Furthermore, In Brazil, over 2.5?billion diagnostic tests were conducted in 2024, including more than 2.7?million blood sample collections through the public system (SUS). Only 21% of basic health units had lab collection facilities, highlighting demand for vacuum blood collection tubes and expanded diagnostic infrastructure nationwide. Moreover, Key trends in the Brazil vacuum blood collection tube market include growing demand for safety and sterile tubes, increasing automation in laboratories, adoption of multi-additive tubes for diverse tests, expansion of private and public healthcare diagnostics, focus on preventive healthcare, and modernization of laboratory infrastructure to enhance efficiency and accuracy. For instance, Recent innovations in Brazil’s include barcoded and RFID-enabled tubes for accurate sample tracking, needle-free and safety-engineered designs to reduce contamination and injuries, multi-additive tubes for simultaneous testing, and biodegradable or eco-friendly materials, enhancing efficiency, safety, and sustainability in laboratory diagnostics.

Report Coverage

This research report categorizes the market for Brazil vacuum blood collection tube market based on various segments and regions, and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Brazil vacuum blood collection tube market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Brazil vacuum blood collection tube market.

Driving Factors

The Brazil vacuum blood collection tube market is driven by increasing demand for safe, efficient, and accurate blood sampling amid rising chronic disease prevalence and expanding diagnostic testing. Government initiatives under SUS facilitated over 2.7?million blood sample collections in 2024, highlighting public sector demand. Innovations such as barcoded and RFID-enabled tubes, needle-free designs, and multi-additive tubes enhance efficiency, safety, and accuracy, while laboratory modernization and preventive healthcare growth further accelerate adoption. Expansion of private healthcare diagnostics, rising awareness of contamination-free collection, and eco-friendly tube materials collectively strengthen market growth and drive widespread utilization across hospitals and laboratories.

Restraining Factors

The Brazil vacuum blood collection tube market faces restraints from high equipment and tube costs, limited availability in rural areas, inadequate laboratory infrastructure in some regions, and dependence on imported supplies. Additionally, a lack of skilled personnel for proper sample handling and low awareness in smaller clinics can hinder widespread adoption.

Market Segmentation

The Brazil vacuum blood collection tube market share is categorized by product type and application. 

• The EDTA tubes segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. 

The Brazil vacuum blood collection tube market is segmented by product type into gel and clot activator tubes, heparin tubes, EDTA tubes, glucose tubes, serum separating tubes, and ERS tubes. Among these, the EDTA tubes segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. The segmental growth is due to their essential role in hematology testing, particularly for complete blood counts (CBC) and other routine blood analyses. Their anticoagulant properties prevent clotting, ensuring accurate cell counts and reliable test results. Hospitals, diagnostic laboratories, and blood banks widely adopt EDTA tubes because hematology tests are among the most common and frequent diagnostic procedures. Additionally, the rising prevalence of chronic diseases, growing preventive healthcare awareness, and expansion of public and private laboratory infrastructure further drive consistent demand for EDTA tubes nationwide.

• The blood routine examination segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.  

The Brazil vacuum blood collection tube market is segmented by application into biochemical test, blood routine examination, coagulation testing, blood segmentation testing, and others. Among these, the blood routine examination segment accounted for the largest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period. The growth of the segment is due to the high frequency and necessity of routine hematology tests, such as complete blood counts (CBC), which are essential for diagnosing infections, anemia, and other common conditions. Hospitals, clinics, and diagnostic laboratories conduct these tests regularly for both preventive checkups and disease monitoring. The growing prevalence of chronic diseases, expansion of healthcare infrastructure, and increased awareness of early diagnosis further boost the demand for vacuum blood collection tubes used specifically for routine blood examinations nationwide.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Brazil vacuum blood collection tube market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies                                                                                                                                      

• Becton, Dickinson and Company (BD)
• Cardinal Health, Inc.
• Sekisui Chemical Co., Ltd.
• Greiner Bio-One International GmbH (GBO)
• Sarstedt AG & Co. KG
• Advin Health Care
• AdvaCare Pharma
• Hindustan Syringes & Medical Devices Ltd.
•  Other

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent News

• In April 2024, Streck introduced Protein Plus BCT, a new direct draw whole blood collection tube designed to stabilize plasma protein concentrations during storage at room temperature. This launch expands the company's product portfolio and strengthens its competitive position in the market.
• In April 2024, Becton, Dickinson, and Company introduced the BD Vacutainer UltraTouch Push Button Blood Collection Set in India. This innovative product features BD RightGauge technology, allowing the use of a thinner needle for blood collection. Combined with BD PentaPoint technology, it significantly reduces insertion pain for patients. This launch expanded the product's geographical availability, promising to increase revenue and broaden the company's customer base.

Market Segment

This study forecasts revenue at the Brazil, regional, and country levels from 2020 to 2035.Decision Advisior has segmented the Brazil vacuum blood collection tube market based on the below-mentioned segments:

Brazil Vacuum Blood Collection Tube Market, By Product Type

• Gel and Clot Activator Tube
• Heparin Tubes
• EDTA Tubes
• Glucose Tubes
• Serum Separating Tubes
• ERS Tubes

Brazil Vacuum Blood Collection Tube Market, By Application

• Biochemical Test
• Blood Routine Examination
• Coagulation Testing
• Blood Segmentation Testing
• Others

FAQ’s

Q1. Why are vacuum blood collection tubes preferred over traditional syringes?

• They ensure precise blood volume collection, reduce contamination risk, and improve patient safety during sampling.

Q2. How is government involvement influencing the market?

• Public health programs under SUS and lab expansion initiatives increase demand for standardized blood collection tubes.

Q3. Which innovations are gaining popularity?

• Needle-free tubes, barcoded/RFID tracking, multi-additive tubes, and biodegradable materials are improving efficiency and safety.

Q4. What limits adoption in Brazil?

• High costs, limited rural lab infrastructure, reliance on imports, and a shortage of trained staff restrict growth.

Q5. Where are these tubes most commonly used?

• In hospitals, diagnostic labs, blood banks, and preventive health centers for routine and specialized testing.

Q6. What trends are shaping future demand?

• Automation in labs, preventive healthcare growth, eco-friendly materials, and increasing chronic disease testing are driving market expansion.???????

Q7. Who are the main suppliers in Brazil?

• BD, Cardinal Health, Greiner Bio-One, Sarstedt, Sekisui Chemical, Advin Health Care, AdvaCare Pharma, Hindustan Syringes & Medical Devices.